Adagene Management
Management criteria checks 1/4
Adagene's CEO is Peizhi Luo, appointed in Nov 2011, has a tenure of 12.42 years. directly owns 3.26% of the company’s shares, worth $3.93M. The average tenure of the management team and the board of directors is 5.5 years and 2.5 years respectively.
Key information
Peizhi Luo
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 12.4yrs |
| CEO ownership | 3.3% |
| Management average tenure | 5.5yrs |
| Board average tenure | 2.5yrs |
Recent management updates
Recent updates
Adagene Inc. (NASDAQ:ADAG) Surges 26% Yet Its Low P/S Is No Reason For Excitement
Oct 10
The Consensus EPS Estimates For Adagene Inc. (NASDAQ:ADAG) Just Fell Dramatically
Oct 05Adagene ADR GAAP EPS of -$0.87 misses by $0.45, revenue of $3.93M misses by $9.82M
Aug 30Micro-cap Adagene surges after hours on $10M share buyback
Jun 29CEO
Peizhi Luo (57 yo)
12.4yrs
Tenure
Dr. Peter P. Luo, PhD, also known as Peizhi, is the Founder of Adagene Inc. and serves as its Chief Executive Officer since November 2011 and Director since February 2018. He serves as President of R&D at...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co- Founder | 12.4yrs | no data | 3.26% $ 3.9m | |
| CFO & Director | 4.6yrs | no data | no data | |
| Chief Scientific Officer | 3.7yrs | no data | no data | |
| Vice President of Investor Relations & Corporate Communications | no data | no data | no data | |
| Head of Human Resources | 4.5yrs | no data | no data | |
| Chief Manufacturing Officer | 3.5yrs | no data | no data | |
| Senior VP of Bioinformatics & Information Technology and Director | 12.4yrs | no data | no data | |
| Senior VP & Head of Clinical Operations | 12.4yrs | no data | 0.52% $ 625.4k | |
| Senior Vice President of Early Drug Discovery | 8.5yrs | no data | no data | |
| VP & Head of Business Development | 6.5yrs | no data | no data | |
| Executive Vice President of Clinical Development | 2.5yrs | no data | no data | |
| VP and Head of Clinical & Quantitative Pharmacology | no data | no data | no data |
5.5yrs
Average Tenure
54yo
Average Age
Experienced Management: ADAG's management team is seasoned and experienced (5.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co- Founder | 6.2yrs | no data | 3.26% $ 3.9m | |
| CFO & Director | 3.2yrs | no data | no data | |
| Senior VP of Bioinformatics & Information Technology and Director | 1.3yrs | no data | no data | |
| Member of Scientific & Strategic Advisory Board | 2.7yrs | no data | no data | |
| Member Scientific and Strategic Advisory Board | 2.7yrs | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | 1.4yrs | no data | no data | |
| Member Scientific & Strategic Advisory Board | 2.3yrs | no data | no data | |
| Director | less than a year | no data | no data | |
| Member of Scientific & Strategic Advisory Board | 1.1yrs | no data | no data | |
| Independent Director | 3.2yrs | no data | no data | |
| Member Scientific & Strategic Advisory Board | 2.7yrs | no data | no data |
2.5yrs
Average Tenure
63yo
Average Age
Experienced Board: ADAG's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.